The Traderszone Network

21 July, 2014 by The TZ Newswire Staff Comments Off on Halliburton profit up 20 percent on higher U.S. drilling activity

Halliburton profit up 20 percent on higher U.S. drilling activity

Halliburton Co , the world’s No. 2 oilfield services provider, reported a 20 percent rise in quarterly profit as drilling activity increased in the United States and the Gulf of Mexico. The company also …

21 July, 2014 by The TZ Newswire Staff Comments Off on The Wall Street Journal: Reynolds vows to fight $23.6 billion verdict

The Wall Street Journal: Reynolds vows to fight $23.6 billion verdict

Size of jury award in smoking case is likely to decline.
read more

21 July, 2014 by The TZ Newswire Staff Comments Off on The Wall Street Journal: Gaza deaths top 500 after night of Israeli attacks

The Wall Street Journal: Gaza deaths top 500 after night of Israeli attacks

Israel repels two underground infiltrations by Hamas militants from the Gaza Strip following a night of Israeli attacks that left a heavy toll of casualties in the Palestinian territory.
read more

21 July, 2014 by The TZ Newswire Staff Comments Off on Why next two weeks’ earnings may test economy

Why next two weeks’ earnings may test economy

A long hoped for improvement in the economy appears to be manifesting in second-quarter U.S. earnings, but the next two weeks could be the real test.

21 July, 2014 by The TZ Newswire Staff Comments Off on Chuck Jaffe: The right way to pick a new mutual fund

Chuck Jaffe: The right way to pick a new mutual fund

Chuck Jaffe describes his 7-step process for adding mutual funds and ETFs to a portfolio.
read more

21 July, 2014 by The TZ Newswire Staff Comments Off on GM orders sales halt for recalled Cadillacs

GM orders sales halt for recalled Cadillacs

GM has ordered Cadillac dealers to stop selling some recalled models because it doesn’t have a fix yet for an ignition problem.

21 July, 2014 by The TZ Newswire Staff Comments Off on Valeant complains to regulators about Allergan

Valeant complains to regulators about Allergan

Valeant is going to regulators over claims made by Allergan to counter a hostile takeover, sources have told CNBC.